These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37544625)

  • 1. Clinical Outcomes of Decompensated Heart Failure With Reduced Ejection Fraction Admissions With or Without Atrial Fibrillation and Atrial Flutter.
    Tamimi O; Tamimi F; Gorthi J
    Curr Probl Cardiol; 2024 Jan; 49(1 Pt A):102014. PubMed ID: 37544625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of atrial fibrillation in acute decompensated heart failure with reduced versus preserved ejection fraction.
    Jobs A; Schwind J; Katalinic A; Babaev V; Tilz RR; Rausch S; Thiele H; Eitel I; Eitel C
    Clin Res Cardiol; 2019 Jan; 108(1):74-82. PubMed ID: 29987595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial resynchronization therapy in patients with atrial fibrillation and heart failure with and without systolic left ventricular dysfunction: a pilot study.
    Saksena S; Slee A; Saad M
    J Interv Card Electrophysiol; 2018 Oct; 53(1):9-17. PubMed ID: 29987682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of incident atrial fibrillation in heart failure with preserved or reduced ejection fraction: A community-based study.
    Zhang P; Chamberlain AM; Hodge DO; Cai C; Xiao PL; Han J; Jiang CY; Redfield MM; Roger VL; Cha YM
    J Cardiovasc Electrophysiol; 2020 Sep; 31(9):2275-2283. PubMed ID: 32584498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation is an independent risk factor for heart failure hospitalization in heart failure with preserved ejection fraction.
    Yang E; Vaishnav J; Song E; Lee J; Schulman S; Calkins H; Berger R; Russell SD; Sharma K
    ESC Heart Fail; 2022 Oct; 9(5):2918-2927. PubMed ID: 35712815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. History of Atrial Fibrillation and Trajectory of Decongestion in Acute Heart Failure.
    Patel RB; Vaduganathan M; Rikhi A; Chakraborty H; Greene SJ; Hernandez AF; Felker GM; Redfield MM; Butler J; Shah SJ
    JACC Heart Fail; 2019 Jan; 7(1):47-55. PubMed ID: 30409707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of heart failure with procedural complications and in-hospital outcomes from left atrial appendage occlusion device implantation in patients with atrial fibrillation: insights from the national inpatient sample of 62 980 procedures.
    Munir MB; Khan MZ; Darden D; Abideen Asad ZU; Osman M; Singh GD; Srivatsa UN; Han FT; Reeves R; Hsu JC
    Europace; 2022 Oct; 24(9):1451-1459. PubMed ID: 35613020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes in Patients With Heart Failure With Reduced Ejection Fraction During Hospitalization: A Retrospective Observational Study.
    Zhou Y; Wang M; Wang S; Li N; Zhang S; Tang S; Shi Q; Zhao Y; Li J; Zeng Y; Song H; Tian H; Li S; Li S
    Front Endocrinol (Lausanne); 2021; 12():727188. PubMed ID: 34456878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart failure and the risk of left atrial thrombus formation in patients with atrial fibrillation or atrial flutter.
    Wybraniec MT; Mizia-Szubryt M; Cichoń M; Wrona-Kolasa K; Kapłon-Cieślicka A; Gawałko M; Budnik M; Uziębło-Życzkowska B; Krzesiński P; Starzyk K; Gorczyca-Głowacka I; Daniłowicz-Szymanowicz L; Kaufmann D; Wójcik M; Błaszczyk R; Hiczkiewicz J; Łojewska K; Kosmalska K; Fijałkowski M; Szymańska A; Wiktorska A; Haberka M; Kucio M; Michalski B; Kupczyńska K; Tomaszuk-Kazberuk A; Wilk-Śledziewska K; Wachnicka-Truty R; Koziński M; Burchardt P; Mizia-Stec K
    ESC Heart Fail; 2022 Dec; 9(6):4064-4076. PubMed ID: 36039813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U; Dahlström U; Fu M; Lund LH
    JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial.
    Vaduganathan M; Piccini JP; Camm AJ; Crijns HJGM; Anker SD; Butler J; Stewart J; Braceras R; Albuquerque APA; Wieloch M; Hohnloser SH
    Eur J Heart Fail; 2022 Jun; 24(6):1094-1101. PubMed ID: 35293087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends and Outcomes of Atrial Fibrillation-Flutter Hospitalizations Among Heart Transplant Recipients (From the National Inpatient Sample).
    Voruganti D; Shantha G; Dugyala S; Pothineni NVK; Agnihotri K; Bozorgnia B; Amanullah A; Giudici M; Briasoulis A
    Am J Cardiol; 2020 Jan; 125(1):87-91. PubMed ID: 31685214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild and moderate to severe early acute kidney injury following cardiac surgery among patients with heart failure and preserved vs. mid-range vs. reduced ejection fraction: A retrospective cohort study.
    Gao Y; Wang C; Li J; Ji B; Wang J; Yan F; Wang Y
    Eur J Anaesthesiol; 2022 Aug; 39(8):673-684. PubMed ID: 35791895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Atrial Fibrillation on Hospitalization Outcomes of Heart Failure in Patients ≥ 60 Years with Implantable Cardioverter Defibrillator.
    Abugroun A; Elawad A; Okoh AK; Abdel-Rahman ME; Ayinde H; Volgman AS
    Am J Cardiol; 2021 Aug; 152():94-98. PubMed ID: 34090659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 and Heart Failure with Preserved and Reduced Ejection Fraction Clinical Outcomes among Hospitalized Patients in the United States.
    Nasrullah A; Gangu K; Cannon HR; Khan UA; Shumway NB; Bobba A; Sagheer S; Chourasia P; Shuja H; Avula SR; Shekhar R; Sheikh AB
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of congestive heart failure and left ventricular systolic function on the prognostic significance of atrial fibrillation and atrial flutter following acute myocardial infarction.
    Pedersen OD; Bagger H; Køber L; Torp-Pedersen C;
    Int J Cardiol; 2005 Apr; 100(1):65-71. PubMed ID: 15820287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks of Heart Failure, Stroke, and Bleeding in Atrial Fibrillation According to Heart Failure Phenotypes.
    Inciardi RM; Giugliano RP; Park JG; Nordio F; Ruff CT; Chen C; Lanz HJ; Antman EM; Braunwald E; Solomon SD
    JACC Clin Electrophysiol; 2023 Apr; 9(4):569-580. PubMed ID: 37100536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between sodium-glucose cotransporter-2 inhibitors and incident atrial fibrillation/atrial flutter in heart failure patients with reduced ejection fraction: a meta-analysis of randomized controlled trials.
    Sfairopoulos D; Liu T; Zhang N; Tse G; Bazoukis G; Letsas K; Goudis C; Milionis H; Vrettos A; Korantzopoulos P
    Heart Fail Rev; 2023 Jul; 28(4):925-936. PubMed ID: 36282460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Relationship Between Atrial Fibrillation, Mitral Regurgitation, and Heart Failure Subtype: The ARIC Study.
    Arora S; Brown ZD; Sivaraj K; Hendrickson MJ; Mazzella AJ; Chang PP; Vaduganathan M; Qamar A; Gehi AK; Pandey A; Vavalle JP
    J Card Fail; 2022 Jun; 28(6):883-892. PubMed ID: 34955335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Prognostic Impact of Atrial Fibrillation in Hospitalized Heart Failure Patients With Preserved Ejection Fraction According to Coronary Artery Disease Status　- Report From the Japanese Nationwide Multicenter Registry.
    Temma T; Nagai T; Watanabe M; Kamada R; Takahashi Y; Hagiwara H; Koya T; Nakao M; Omote K; Kamiya K; Iwano H; Yamamoto K; Yoshikawa T; Saito Y; Anzai T
    Circ J; 2020 Feb; 84(3):397-403. PubMed ID: 32009066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.